Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12,088 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Nutrient deprivation and hypoxia alter T cell immune checkpoint expression: potential impact for immunotherapy.
Davern M, Donlon NE, O'Connell F, Gaughan C, O'Donovan C, McGrath J, Sheppard AD, Hayes C, King R, Temperley H, MacLean M, Bulter C, Bhardwaj A, Moore J, Donohoe C, Ravi N, Conroy MJ, Reynolds JV, Lysaght J. Davern M, et al. Among authors: moore j. J Cancer Res Clin Oncol. 2023 Jul;149(8):5377-5395. doi: 10.1007/s00432-022-04440-0. Epub 2022 Nov 29. J Cancer Res Clin Oncol. 2023. PMID: 36445478 Free PMC article.
Cooperation between chemotherapy and immune checkpoint blockade to enhance anti-tumour T cell immunity in oesophageal adenocarcinoma.
Davern M, Donlon NE, O' Connell F, Sheppard AD, Hayes C, King R, Temperley H, Butler C, Bhardwaj A, Moore J, Bracken-Clarke D, Donohoe C, Ravi N, Reynolds JV, Maher SG, Conroy MJ, Lysaght J. Davern M, et al. Among authors: moore j. Transl Oncol. 2022 Jun;20:101406. doi: 10.1016/j.tranon.2022.101406. Epub 2022 Mar 30. Transl Oncol. 2022. PMID: 35366537 Free PMC article.
Acidosis significantly alters immune checkpoint expression profiles of T cells from oesophageal adenocarcinoma patients.
Davern M, Donlon NE, O'Connell F, Gaughan C, O'Donovan C, Habash M, Sheppard AD, MacLean M, Dunne MR, Moore J, Temperley H, Conroy MJ, Butler C, Bhardwaj A, Ravi N, Donohoe CL, Reynolds JV, Lysaght J. Davern M, et al. Among authors: moore j. Cancer Immunol Immunother. 2023 Jan;72(1):55-71. doi: 10.1007/s00262-022-03228-y. Epub 2022 Jun 16. Cancer Immunol Immunother. 2023. PMID: 35708739 Free PMC article.
Modern oncological and operative outcomes in oesophageal cancer: the St. James's hospital experience.
Donlon NE, Ravi N, King S, Cunninhgam M, Cuffe S, Lowery M, Wall C, Hughes N, Muldoon C, Ryan C, Moore J, O'Farrell C, Gorry C, Duff AM, Enright C, Nugent TS, Elliot JA, Donohoe CL, Reynolds JV. Donlon NE, et al. Among authors: moore j. Ir J Med Sci. 2021 Feb;190(1):297-305. doi: 10.1007/s11845-020-02321-4. Epub 2020 Jul 21. Ir J Med Sci. 2021. PMID: 32696244
Superiority of anti-reflux stent compared with conventional stents in the palliative management of patients with cancer of the lower esophagus and esophago-gastric junction: results of a randomized clinical trial.
Power C, Byrne PJ, Lim K, Ravi N, Moore J, Fitzgerald T, Keeling PW, Reynolds JV. Power C, et al. Among authors: moore j. Dis Esophagus. 2007;20(6):466-70. doi: 10.1111/j.1442-2050.2007.00696.x. Dis Esophagus. 2007. PMID: 17958720 Clinical Trial.
12,088 results
You have reached the last available page of results. Please see the User Guide for more information.